Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
954
archived clinical trials in
Fibromyalgia

Using Saline for Myofascial Pain Syndromes (USAMPS)
Using Saline for Myofascial Pain Syndromes (USAMPS)
Status: Enrolling
Updated:  6/11/2015
Memorial Hermann Hospital, Texas Medical Center
mi
from
Houston, TX
Using Saline for Myofascial Pain Syndromes (USAMPS)
Using Saline for Myofascial Pain Syndromes (USAMPS)
Status: Enrolling
Updated: 6/11/2015
Memorial Hermann Hospital, Texas Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia
The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia
Status: Enrolling
Updated:  7/21/2015
Cleveland Sleep Research Center
mi
from
Middleburg Heights, OH
The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia
The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia
Status: Enrolling
Updated: 7/21/2015
Cleveland Sleep Research Center
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Whole Body Hyperthermia Registry Study
Status: Enrolling
Updated:  7/23/2015
University of Arizona
mi
from
Tucson, AZ
Whole Body Hyperthermia Registry Study
Status: Enrolling
Updated: 7/23/2015
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
Whole Body Hyperthermia (WBH) as a Rapid Treatment for Fibromyalgia
Whole Body Hyperthermia (WBH) as a Rapid Treatment for Fibromyalgia
Status: Enrolling
Updated:  7/23/2015
University of Arizona
mi
from
Tucson, AZ
Whole Body Hyperthermia (WBH) as a Rapid Treatment for Fibromyalgia
Whole Body Hyperthermia (WBH) as a Rapid Treatment for Fibromyalgia
Status: Enrolling
Updated: 7/23/2015
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
Web-Based Program for Symptom Management in Fibromyalgia
Web-Based Program for Symptom Management in Fibromyalgia
Status: Enrolling
Updated:  8/3/2015
Collinge and Associates
mi
from
Eugene, OR
Web-Based Program for Symptom Management in Fibromyalgia
Web-Based Program for Symptom Management in Fibromyalgia
Status: Enrolling
Updated: 8/3/2015
Collinge and Associates
mi
from
Eugene, OR
Click here to add this to my saved trials
Safety and Efficacy of AGN 203818 for Pain Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated:  8/25/2015
Clinical Research Facility
mi
from
Canton, OH
Safety and Efficacy of AGN 203818 for Pain Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated: 8/25/2015
Clinical Research Facility
mi
from
Canton, OH
Click here to add this to my saved trials
Safety and Efficacy of AGN 203818 for Pain Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated:  8/25/2015
mi
from
Geneva,
Safety and Efficacy of AGN 203818 for Pain Associated With Fibromyalgia Syndrome
Status: Enrolling
Updated: 8/25/2015
mi
from
Geneva,
Click here to add this to my saved trials
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - St. Joseph Mercy Oakland
A Double-Blinded, Randomized, Sham-Controlled, Proof of Concept Study Exploring the Safety and Efficacy of RINCE Technology for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated:  9/2/2015
St. Joseph Mercy Oakland
mi
from
Pontiac, MI
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - St. Joseph Mercy Oakland
A Double-Blinded, Randomized, Sham-Controlled, Proof of Concept Study Exploring the Safety and Efficacy of RINCE Technology for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated: 9/2/2015
St. Joseph Mercy Oakland
mi
from
Pontiac, MI
Click here to add this to my saved trials
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  9/2/2015
Achieve Clinical Research
mi
from
Birmingham, AL
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 9/2/2015
Achieve Clinical Research
mi
from
Birmingham, AL
Click here to add this to my saved trials
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  9/2/2015
Premier Research
mi
from
Phoenix, AZ
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 9/2/2015
Premier Research
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  9/2/2015
Neurovations
mi
from
Napa, CA
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 9/2/2015
Neurovations
mi
from
Napa, CA
Click here to add this to my saved trials
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  9/2/2015
Superior Research LLC
mi
from
Sacramento, CA
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 9/2/2015
Superior Research LLC
mi
from
Sacramento, CA
Click here to add this to my saved trials
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  9/2/2015
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 9/2/2015
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  9/2/2015
Avail Clinical Research
mi
from
DeLand, FL
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 9/2/2015
Avail Clinical Research
mi
from
DeLand, FL
Click here to add this to my saved trials
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  9/2/2015
Compass Research LLC
mi
from
Orlando, FL
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 9/2/2015
Compass Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  9/2/2015
Chicago Research Center, Inc
mi
from
Chicago, IL
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 9/2/2015
Chicago Research Center, Inc
mi
from
Chicago, IL
Click here to add this to my saved trials
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  9/2/2015
Michigan Head Pain & Neurological Institute
mi
from
Ann Arbor, MI
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 9/2/2015
Michigan Head Pain & Neurological Institute
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  9/2/2015
Fieve Clinical Research
mi
from
New York, NY
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 9/2/2015
Fieve Clinical Research
mi
from
New York, NY
Click here to add this to my saved trials
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  9/2/2015
Upstate Clinical Research Associates
mi
from
Williamsville, NY
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 9/2/2015
Upstate Clinical Research Associates
mi
from
Williamsville, NY
Click here to add this to my saved trials
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  9/2/2015
University of Cincinnati College of Medicine
mi
from
Cincinnati, OH
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 9/2/2015
University of Cincinnati College of Medicine
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  9/2/2015
Sunstone Medical Research, LLC
mi
from
Medford, OR
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 9/2/2015
Sunstone Medical Research, LLC
mi
from
Medford, OR
Click here to add this to my saved trials
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  9/2/2015
Omega Medical Research
mi
from
Warwick, RI
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 9/2/2015
Omega Medical Research
mi
from
Warwick, RI
Click here to add this to my saved trials
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  9/2/2015
The Fatigue Consultation Clinic
mi
from
Salt Lake City, UT
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 9/2/2015
The Fatigue Consultation Clinic
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  9/2/2015
Swedish Clinical Research
mi
from
Seattle, WA
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301
A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 9/2/2015
Swedish Clinical Research
mi
from
Seattle, WA
Click here to add this to my saved trials
Prospective Evaluation of Reduced Impedance Noninvasive Cortical Electrostimulation (RINCE) to Reduce Fibromyalgia Effects - Extension Study
An Open Label Extension Trial for Patients With Fibromyalgia Who Complete Study NPT-201 (NCT01825954) and Who Experience Inadequate Pain Reduction
Status: Enrolling
Updated:  9/2/2015
St. Joseph Mercy Oakland
mi
from
Pontiac, MI
Prospective Evaluation of Reduced Impedance Noninvasive Cortical Electrostimulation (RINCE) to Reduce Fibromyalgia Effects - Extension Study
An Open Label Extension Trial for Patients With Fibromyalgia Who Complete Study NPT-201 (NCT01825954) and Who Experience Inadequate Pain Reduction
Status: Enrolling
Updated: 9/2/2015
St. Joseph Mercy Oakland
mi
from
Pontiac, MI
Click here to add this to my saved trials
The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients
The Effect of Milnacipran on Fatigue and Quality of Life in a Lupus Cohort
Status: Enrolling
Updated:  9/17/2015
Loma Linda University Medical Center
mi
from
Loma Linda, CA
The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients
The Effect of Milnacipran on Fatigue and Quality of Life in a Lupus Cohort
Status: Enrolling
Updated: 9/17/2015
Loma Linda University Medical Center
mi
from
Loma Linda, CA
Click here to add this to my saved trials
The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients
The Effect of Milnacipran on Fatigue and Quality of Life in a Lupus Cohort
Status: Enrolling
Updated:  9/17/2015
Loma Linda University Medical Center
mi
from
Loma Linda, CA
The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients
The Effect of Milnacipran on Fatigue and Quality of Life in a Lupus Cohort
Status: Enrolling
Updated: 9/17/2015
Loma Linda University Medical Center
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Effects of Low Dose Naltrexone in Fibromyalgia
Effects of Low Dose Naltrexone in Fibromyalgia
Status: Enrolling
Updated:  9/21/2015
Stanford University School of Medicine
mi
from
Stanford, CA
Effects of Low Dose Naltrexone in Fibromyalgia
Effects of Low Dose Naltrexone in Fibromyalgia
Status: Enrolling
Updated: 9/21/2015
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Complementary and Alternative Medicine (CAM) for Fibromyalgia
Status: Enrolling
Updated:  9/22/2015
Oregon Health and Science University
mi
from
Portland, OR
Complementary and Alternative Medicine (CAM) for Fibromyalgia
Status: Enrolling
Updated: 9/22/2015
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Determining How the Nervous System Processes Pain in Adults With Fibromyalgia
Imaging the Cognitive Modulation of Pain
Status: Enrolling
Updated:  10/1/2015
University of Wisconsin-Madison
mi
from
Madison, WI
Determining How the Nervous System Processes Pain in Adults With Fibromyalgia
Imaging the Cognitive Modulation of Pain
Status: Enrolling
Updated: 10/1/2015
University of Wisconsin-Madison
mi
from
Madison, WI
Click here to add this to my saved trials
Brain Rhythms in Fibromyalgia: A Magnetoencephalography (MEG) Study
Brain Rhythms in Fibromyalgia: A Magnetoencephalography (MEG) Study
Status: Enrolling
Updated:  10/5/2015
NYU Center for the Study & Treatment of Pain
mi
from
New York, NY
Brain Rhythms in Fibromyalgia: A Magnetoencephalography (MEG) Study
Brain Rhythms in Fibromyalgia: A Magnetoencephalography (MEG) Study
Status: Enrolling
Updated: 10/5/2015
NYU Center for the Study & Treatment of Pain
mi
from
New York, NY
Click here to add this to my saved trials
Brain Rhythms in Fibromyalgia: A Magnetoencephalography (MEG) Study
Brain Rhythms in Fibromyalgia: A Magnetoencephalography (MEG) Study
Status: Enrolling
Updated:  10/5/2015
NYU School of Medicine; Center for Neuromagnetism
mi
from
New York, NY
Brain Rhythms in Fibromyalgia: A Magnetoencephalography (MEG) Study
Brain Rhythms in Fibromyalgia: A Magnetoencephalography (MEG) Study
Status: Enrolling
Updated: 10/5/2015
NYU School of Medicine; Center for Neuromagnetism
mi
from
New York, NY
Click here to add this to my saved trials
Study of Gralise to Treat Fibromyalgia Patients
Open Labeled, Non-randomized, Study of Efficacy and Safety of Gralise in Fibromyalgia Patients.
Status: Enrolling
Updated:  10/13/2015
Center for Clinical Research
mi
from
Winston Salem, NC
Study of Gralise to Treat Fibromyalgia Patients
Open Labeled, Non-randomized, Study of Efficacy and Safety of Gralise in Fibromyalgia Patients.
Status: Enrolling
Updated: 10/13/2015
Center for Clinical Research
mi
from
Winston Salem, NC
Click here to add this to my saved trials
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
A 12-Month, Multicenter, Open-Label Extension Study (F202) to Evaluate the Long-term Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  10/23/2015
Radiant Research, Inc.
mi
from
Denver, CO
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
A 12-Month, Multicenter, Open-Label Extension Study (F202) to Evaluate the Long-term Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 10/23/2015
Radiant Research, Inc.
mi
from
Denver, CO
Click here to add this to my saved trials
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
A 12-Month, Multicenter, Open-Label Extension Study (F202) to Evaluate the Long-term Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  10/23/2015
16176 Cortez Boulevard
mi
from
Brooksville, FL
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
A 12-Month, Multicenter, Open-Label Extension Study (F202) to Evaluate the Long-term Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 10/23/2015
16176 Cortez Boulevard
mi
from
Brooksville, FL
Click here to add this to my saved trials
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
A 12-Month, Multicenter, Open-Label Extension Study (F202) to Evaluate the Long-term Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  10/23/2015
100 West Gore Street
mi
from
Orlando, FL
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
A 12-Month, Multicenter, Open-Label Extension Study (F202) to Evaluate the Long-term Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 10/23/2015
100 West Gore Street
mi
from
Orlando, FL
Click here to add this to my saved trials
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
A 12-Month, Multicenter, Open-Label Extension Study (F202) to Evaluate the Long-term Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  10/23/2015
71 Thomas Johnson Drive
mi
from
Frederick, MD
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
A 12-Month, Multicenter, Open-Label Extension Study (F202) to Evaluate the Long-term Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 10/23/2015
71 Thomas Johnson Drive
mi
from
Frederick, MD
Click here to add this to my saved trials
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
A 12-Month, Multicenter, Open-Label Extension Study (F202) to Evaluate the Long-term Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  10/23/2015
370 Faunce Corner Road
mi
from
North Dartmouth, MA
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
A 12-Month, Multicenter, Open-Label Extension Study (F202) to Evaluate the Long-term Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 10/23/2015
370 Faunce Corner Road
mi
from
North Dartmouth, MA
Click here to add this to my saved trials
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
A 12-Month, Multicenter, Open-Label Extension Study (F202) to Evaluate the Long-term Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  10/23/2015
Clinical Pharmacology Study Group
mi
from
Worcester, MA
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
A 12-Month, Multicenter, Open-Label Extension Study (F202) to Evaluate the Long-term Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 10/23/2015
Clinical Pharmacology Study Group
mi
from
Worcester, MA
Click here to add this to my saved trials
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
A 12-Month, Multicenter, Open-Label Extension Study (F202) to Evaluate the Long-term Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  10/23/2015
CRC of Jackson
mi
from
Jackson, MS
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
A 12-Month, Multicenter, Open-Label Extension Study (F202) to Evaluate the Long-term Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 10/23/2015
CRC of Jackson
mi
from
Jackson, MS
Click here to add this to my saved trials
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
A 12-Month, Multicenter, Open-Label Extension Study (F202) to Evaluate the Long-term Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  10/23/2015
University of Cincinnati College of Medicine
mi
from
Cincinnati, OH
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
A 12-Month, Multicenter, Open-Label Extension Study (F202) to Evaluate the Long-term Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 10/23/2015
University of Cincinnati College of Medicine
mi
from
Cincinnati, OH
Click here to add this to my saved trials
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
A 12-Month, Multicenter, Open-Label Extension Study (F202) to Evaluate the Long-term Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  10/23/2015
1275 Olentangy River Road
mi
from
Columbus, OH
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
A 12-Month, Multicenter, Open-Label Extension Study (F202) to Evaluate the Long-term Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 10/23/2015
1275 Olentangy River Road
mi
from
Columbus, OH
Click here to add this to my saved trials
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
A 12-Month, Multicenter, Open-Label Extension Study (F202) to Evaluate the Long-term Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  10/23/2015
18660 Bagley Road
mi
from
Middleburg Heights, OH
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
A 12-Month, Multicenter, Open-Label Extension Study (F202) to Evaluate the Long-term Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 10/23/2015
18660 Bagley Road
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
A 12-Month, Multicenter, Open-Label Extension Study (F202) to Evaluate the Long-term Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  10/23/2015
1001 South Market Street
mi
from
Mechanicsburg, PA
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
A 12-Month, Multicenter, Open-Label Extension Study (F202) to Evaluate the Long-term Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 10/23/2015
1001 South Market Street
mi
from
Mechanicsburg, PA
Click here to add this to my saved trials
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
A 12-Month, Multicenter, Open-Label Extension Study (F202) to Evaluate the Long-term Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  10/23/2015
322 Memorial Drive
mi
from
Greer, SC
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
A 12-Month, Multicenter, Open-Label Extension Study (F202) to Evaluate the Long-term Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 10/23/2015
322 Memorial Drive
mi
from
Greer, SC
Click here to add this to my saved trials
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
A 12-Month, Multicenter, Open-Label Extension Study (F202) to Evaluate the Long-term Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  10/23/2015
601 Broadway
mi
from
Seattle, WA
12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients
A 12-Month, Multicenter, Open-Label Extension Study (F202) to Evaluate the Long-term Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 10/23/2015
601 Broadway
mi
from
Seattle, WA
Click here to add this to my saved trials
BEdtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT)
A Phase 2b, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  11/5/2015
Radiant Research, Inc.
mi
from
Denver, CO
BEdtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT)
A Phase 2b, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 11/5/2015
Radiant Research, Inc.
mi
from
Denver, CO
Click here to add this to my saved trials
BEdtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT)
A Phase 2b, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  11/5/2015
16176 Cortez Boulevard
mi
from
Brooksville, FL
BEdtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT)
A Phase 2b, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 11/5/2015
16176 Cortez Boulevard
mi
from
Brooksville, FL
Click here to add this to my saved trials
BEdtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT)
A Phase 2b, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  11/5/2015
100 West Gore Street
mi
from
Orlando, FL
BEdtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT)
A Phase 2b, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 11/5/2015
100 West Gore Street
mi
from
Orlando, FL
Click here to add this to my saved trials
BEdtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT)
A Phase 2b, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  11/5/2015
71 Thomas Johnson Drive
mi
from
Frederick, MD
BEdtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT)
A Phase 2b, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 11/5/2015
71 Thomas Johnson Drive
mi
from
Frederick, MD
Click here to add this to my saved trials